OBJECTIVE: Colonization pressure is an important infection control metric. The aim of this study was to describe the definition and measurement of and adjustment for colonization pressure in nosocomial-acquisition risk factor studies of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Clostridium difficile. METHODS: We performed a computerized search of studies of nosocomial MRSA, VRE, and C. difficile acquisition published before July 1, 2009, through MEDLINE. Studies were included if a study outcome was MRSA, VRE, or C. difficile acquisition; the authors identified risk factors associated with MRSA, VRE, or C. difficile acquisition; and the study measured colonization pressure. RESULTS: The initial MEDLINE search yielded 505 articles. Sixty-six of these were identified as studies of nosocomial MRSA, VRE, or C. difficile acquisition; of these, 18 (27%) measured colonization pressure and were included in the final review. The definition of colonization pressure varied considerably between studies: the proportion of MRSA- or VRE-positive patients (5 studies), the proportion of MRSA- or VRE-positive patient-days (6 studies), or the total or mean number of MRSA-, VRE-, or C. difficile-positive patients or patient-days (7 studies) in the unit over periods of varying length. In 10 of 13 studies, colonization pressure was independently associated with MRSA, VRE, or C. difficile acquisition. CONCLUSION: There is a need for a simple and consistent method to quantify colonization pressure in both research and routine clinical care to accurately assess the effect of colonization pressure on cross-transmission of antibiotic-resistant bacteria.
OBJECTIVE: Colonization pressure is an important infection control metric. The aim of this study was to describe the definition and measurement of and adjustment for colonization pressure in nosocomial-acquisition risk factor studies of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Clostridium difficile. METHODS: We performed a computerized search of studies of nosocomial MRSA, VRE, and C. difficile acquisition published before July 1, 2009, through MEDLINE. Studies were included if a study outcome was MRSA, VRE, or C. difficile acquisition; the authors identified risk factors associated with MRSA, VRE, or C. difficile acquisition; and the study measured colonization pressure. RESULTS: The initial MEDLINE search yielded 505 articles. Sixty-six of these were identified as studies of nosocomial MRSA, VRE, or C. difficile acquisition; of these, 18 (27%) measured colonization pressure and were included in the final review. The definition of colonization pressure varied considerably between studies: the proportion of MRSA- or VRE-positive patients (5 studies), the proportion of MRSA- or VRE-positive patient-days (6 studies), or the total or mean number of MRSA-, VRE-, or C. difficile-positive patients or patient-days (7 studies) in the unit over periods of varying length. In 10 of 13 studies, colonization pressure was independently associated with MRSA, VRE, or C. difficile acquisition. CONCLUSION: There is a need for a simple and consistent method to quantify colonization pressure in both research and routine clinical care to accurately assess the effect of colonization pressure on cross-transmission of antibiotic-resistant bacteria.
Authors: Adam L Cohen; David Calfee; Scott K Fridkin; Susan S Huang; John A Jernigan; Ebbing Lautenbach; Shannon Oriola; Keith M Ramsey; Cassandra D Salgado; Robert A Weinstein Journal: Infect Control Hosp Epidemiol Date: 2008-10 Impact factor: 3.254
Authors: J Merrer; F Santoli; C Appéré de Vecchi; B Tran; B De Jonghe; H Outin Journal: Infect Control Hosp Epidemiol Date: 2000-11 Impact factor: 3.254
Authors: Marci Drees; David R Snydman; Christopher H Schmid; Laurie Barefoot; Karen Hansjosten; Padade M Vue; Michael Cronin; Stanley A Nasraway; Yoav Golan Journal: Clin Infect Dis Date: 2008-03-01 Impact factor: 9.079
Authors: A D Harris; E N Perencevich; J K Johnson; D L Paterson; J G Morris; S M Strauss; J A Johnson Journal: Clin Infect Dis Date: 2007-10-16 Impact factor: 9.079
Authors: Alexander L A Bloemendaal; Ad C Fluit; Wouter M T Jansen; Menno R Vriens; Tristan Ferry; Laurent Argaud; Jose M Amorim; A C Resende; Alvaro Pascual; Lorena López-Cerero; Stefania Stefani; Giacomo Castiglione; Penelope Evangelopoulou; Sophia Tsiplakou; Inne H M Borel Rinkes; Jan Verhoef Journal: Infect Control Hosp Epidemiol Date: 2009-02 Impact factor: 3.254
Authors: Erik R Dubberke; Kimberly A Reske; Margaret A Olsen; Kathleen M McMullen; Jennie L Mayfield; L Clifford McDonald; Victoria J Fraser Journal: Arch Intern Med Date: 2007-05-28
Authors: Erik R Dubberke; Kimberly A Reske; Yan Yan; Margaret A Olsen; L Clifford McDonald; Victoria J Fraser Journal: Clin Infect Dis Date: 2007-12-15 Impact factor: 9.079
Authors: M Papadimitriou-Olivgeris; E Drougka; F Fligou; F Kolonitsiou; A Liakopoulos; V Dodou; E D Anastassiou; E Petinaki; M Marangos; K S Filos; I Spiliopoulou Journal: Infection Date: 2014-08-21 Impact factor: 3.553
Authors: Mandy Bodily; Kathleen M McMullen; Anthony J Russo; Nupur D Kittur; Joan Hoppe-Bauer; David K Warren Journal: Infect Control Hosp Epidemiol Date: 2013-06-27 Impact factor: 3.254
Authors: Keyvan Razazi; Lennie P G Derde; Marine Verachten; Patrick Legrand; Philippe Lesprit; Christian Brun-Buisson Journal: Intensive Care Med Date: 2012-08-15 Impact factor: 17.440
Authors: Adebola O Ajao; J Kristie Johnson; Anthony D Harris; Min Zhan; Jessina C McGregor; Kerri A Thom; Jon P Furuno Journal: Infect Control Hosp Epidemiol Date: 2013-05 Impact factor: 3.254
Authors: Victor O Popoola; Karen C Carroll; Tracy Ross; Nicholas G Reich; Trish M Perl; Aaron M Milstone Journal: Clin Infect Dis Date: 2013-08-13 Impact factor: 9.079